The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.125
Bid: 17.75
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.75 (4.225%)
Open: 18.125
High: 18.125
Low: 18.125
Prev. Close: 18.125
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix receives British Retail Consortium accreditation

Wed, 05th Jan 2022 15:31

(Alliance News) - OptiBiotix Health PLC announced on Wednesday it had obtained accreditation from the British Retail Consortium, allowing the company to do business with large global retailers.

The BRC certification is the first to meet the Global Food Safety Initiative, enabling the life sciences company to do business with retailers such as Tesco PLC and Walmart Inc.

In addition, it may now sell to other large manufacturers, ingredient companies, and food service organizations who require the certification in their approval process.

Rene Kamminga, chief executive officer of York-based ObtiBiotix, commented: "We are very pleased to announce our BRC accreditation which supports our commercial strategy of selling final product solutions to partners in the retail channel containing our science backed pro and prebiotic ingredients. I am particularly proud of our team which achieved this accreditation in a relatively short period of time."

The life sciences company's share price fell by 2.7% to 45.23 pence each in London on Wednesday afternoon.

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Aug 2021 11:24

OptiBiotix extends deal with Seed Health to other territories

(Sharecast News) - Life sciences company OptiBiotix Health announced on Tuesday that its wholly-owned subsidiary ProBiotix Health has extended the territories of its original agreement with Seed Health, for the production, promotion, marketing and commercialisation of products containing 'LPLDL'.

Read more
5 Aug 2021 18:07

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

IN BRIEF: OptiBiotix Health confident in annual outlook on sales rise

Read more
5 Aug 2021 13:43

OptiBiotix revenues see healthy rise in first half

(Sharecast News) - Obesity, cardiovascular and diabetes-focussed life sciences company OptiBiotix Health reported first-half total invoiced sales of 'LPLDL' and 'SlimBiome' as ingredient or final product of £1.074m in an update on Thursday, representing a year-on-year increase of 44.3% and ahead of its expectations for the period.

Read more
5 Aug 2021 10:44

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

AIM WINNERS & LOSERS: Mkango rises on deal to wholly own Songwe Hill

Read more
6 Jul 2021 11:30

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

IN BRIEF: OptiBiotix continues Asian expansion with Inscobee deal

Read more
2 Jul 2021 15:52

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
17 Jun 2021 13:21

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

TRADING UPDATES: Anpario performance improves; Sumo outlook confident

Read more
17 Jun 2021 12:13

OptiBiotix operating losses narrow as revenue surges

(Sharecast News) - Life sciences company OptiBiotix Health reported a 104% improvement in its full-year revenue on Thursday, to £1.52m.

Read more
21 Apr 2021 14:44

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

IN BRIEF: OptiBiotix Health CEO and division chief buy shares

Read more
16 Apr 2021 15:17

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

DIRECTOR DEALINGS: Tesco chair invests GBP100,000; Dechra exec sells

Read more
23 Mar 2021 15:04

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

EXECUTIVE CHANGES: BT Group Regulatory Affairs Director Ross leaves

Read more
23 Mar 2021 08:06

Optibiotix names René Kamminga as CEO of subsidiary

(Sharecast News) - Biotechnology company Optibiotix Health named René Kamminga as chief executive officer of its OptiBiotix Ltd subsidiary on Tuesday, subject to completion of normal regulatory due diligence.

Read more
17 Mar 2021 15:50

OptiBiotix expands product ranges, sees positive drug trial results

OptiBiotix expands product ranges, sees positive drug trial results

Read more
18 Feb 2021 11:13

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

OptiBiotix Expects To Swing To Annual Profit Thanks To Increased Sales

Read more
2 Feb 2021 14:38

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

IN BRIEF: OptiBiotix Health Hires UK MP Stephen Hammond As Non-Exec

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.